CS
BLUE

Credit Suisse’s bluebird bio BLUE Stock Holding History

Credit Suisse’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,532
Closed -$97.5K – 2958
2023
Q4 		$97.5K Sell
3,532
-85,702
-96% -$5.23M ﹤0.01% 3029
2023
Q3 		$5.43M Sell
89,234
-3,356
-4% -$236K 0.01% 1224
2023
Q2 		$6.09M Buy
92,590
+8,179
+10% +$598K 0.01% 1211
2023
Q1 		$5.37M Buy
84,411
+1,634
+2% +$187K 0.01% 1256
2022
Q4 		$11.5M Buy
82,777
+3,410
+4% +$480K 0.01% 871
2022
Q3 		$10M Sell
79,367
-801
-1% -$90.6K 0.01% 905
2022
Q2 		$6.64M Sell
80,168
-30,070
-27% -$2.33M 0.01% 1125
2022
Q1 		$10.7M Buy
110,238
+273
+0.2% +$36K 0.01% 1018
2021
Q4 		$22M Sell
109,965
-44,766
-29% -$10.6M 0.01% 1044
2021
Q3 		$38.3M Sell
154,731
-48,740
-24% -$13.9M 0.02% 754
2021
Q2 		$84.3M Buy
203,471
+24,256
+14% +$9.61M 0.04% 448
2021
Q1 		$70M Buy
179,215
+62,761
+54% +$30.9M 0.04% 568
2020
Q4 		$65.3M Buy
116,454
+65,363
+128% +$41.4M 0.03% 588
2020
Q3 		$35.7M Sell
51,091
-491
-1% -$383K 0.02% 756
2020
Q2 		$40.8M Buy
51,582
+13,596
+36% +$10.3M 0.03% 618
2020
Q1 		$22.6M Buy
37,986
+10,830
+40% +$10.6M 0.02% 778
2019
Q4 		$30.9M Sell
27,156
-13,592
-33% -$14.8M 0.02% 790
2019
Q3 		$48.5M Buy
40,748
+13,648
+50% +$20.8M 0.04% 466
2019
Q2 		$44.7M Buy
27,100
+2,799
+12% +$4.84M 0.04% 491
2019
Q1 		$49.5M Sell
24,301
-3,061
-11% -$5.39M 0.05% 430
2018
Q4 		$35.2M Buy
27,362
+7,310
+36% +$11.2M 0.04% 513
2018
Q3 		$37.9M Buy
20,052
+4,207
+27% +$8.69M 0.03% 536
2018
Q2 		$32.2M Sell
15,845
-4,620
-23% -$10.5M 0.03% 583
2018
Q1 		$45.3M Buy
20,465
+8,205
+67% +$20.9M 0.04% 452
2017
Q4 		$28.3M Buy
12,260
+4,128
+51% +$8.38M 0.03% 686
2017
Q3 		$14.5M Buy
8,132
+1,168
+17% +$1.63M 0.01% 1032
2017
Q2 		$9.48M Sell
6,964
-2,884
-29% -$3.48M 0.01% 1232
2017
Q1 		$11.6M Buy
9,848
+1,812
+23% +$1.85M 0.01% 1136
2016
Q4 		$6.42M Buy
8,036
+214
+3% +$170K 0.01% 1482
2016
Q3 		$6.87M Buy
7,822
+668
+9% +$484K 0.01% 1426
2016
Q2 		$4.01M Sell
7,154
-1,033
-13% -$585K ﹤0.01% 1790
2016
Q1 		$4.51M Buy
8,187
+2,638
+48% +$1.62M 0.01% 1614
2015
Q4 		$4.62M Buy
5,549
+265
+5% +$265K 0.01% 1644
2015
Q3 		$5.86M Sell
5,284
-6,810
-56% -$12.4M 0.01% 1454
2015
Q2 		$26.4M Buy
12,094
+5,944
+97% +$12.1M 0.03% 691
2015
Q1 		$9.62M Sell
6,150
-850
-12% -$1.12M 0.01% 1221
2014
Q4 		$8.32M Buy
7,000
+648
+10% +$433K 0.01% 1401
2014
Q3 		$2.95M Buy
6,352
+2,338
+58% +$1.08M ﹤0.01% 2183
2014
Q2 		$2.01M Sell
4,014
-428
-10% -$137K ﹤0.01% 2706
2014
Q1 		$1.31M Buy
+4,442
New +$1.35M ﹤0.01% 2872

Other funds holding BLUE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Credit Suisse's BLUE Position: Q1 2024 in Review

Credit Suisse sold out of bluebird bio (BLUE) in Q1 2024, closing a stake of 3,532 shares — an estimated $97.5K sold.

Credit Suisse first reported a position in BLUE in Q1 2014 and held it in 40 quarters. The position peaked at $84.3M in Q2 2021. 158 funds tracked by Wall St. Rank hold BLUE as of Q1 2024.

  • Credit Suisse reported no remaining bluebird bio position as of Q1 2024 after selling out during the quarter.
  • Credit Suisse sold 3,532 bluebird bio shares in Q1 2024, an estimated $97.5K.
  • Credit Suisse first reported a position in bluebird bio in Q1 2014 and held it in 40 quarters.
  • Credit Suisse's bluebird bio position peaked at $84.3M in Q2 2021.
  • 158 funds tracked by Wall St. Rank held bluebird bio as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.